Gene Therapy Technologies Market
Gene Therapy Technologies Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Gene Therapy Technologies Market Size and Growth
The Gene Therapy Technologies market is witnessing robust growth, driven by advancements in genetic engineering and increasing prevalence of genetic disorders. The market size is projected to reach approximately $5 billion by 2027, fueled by rising investments in research and development, regulatory approvals, and expanding therapeutic applications. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Bluebird bio
◍ Adaptimmune
◍ GlaxoSmithKline
◍ Merck
◍ Celgene
◍ Shanghai Sunway Biotech
◍ BioCancell
◍ Shenzhen SiBiono GeneTech
◍ SynerGene Therapeutics
◍ OncoGenex Pharmaceuticals
◍ Genelux Corporation
◍ Cell Genesys
◍ Advantagene
◍ GenVec
◍ BioCancell
◍ Celgene
◍ Epeius Biotechnologies
◍ Introgen Therapeutics
The gene therapy technologies market features diverse players like Bluebird bio, Adaptimmune, and GlaxoSmithKline, who develop innovative therapies targeting genetic disorders and cancers. Companies leverage proprietary technologies to enhance treatment efficacy, driving growth. Selected sales revenues include:
- Bluebird bio: $172 million (2022)
- Merck: $59.3 billion (2022)
- Celgene: $16.46 billion (2019)
Request Sample Report
Market Segmentation
By Application
By Product
Type I
Type II ◍ Cancer Diseases ◍ Monogenic Diseases
◍ Infectious Diseases
◍ Cardiovasular Diseases ◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
